How much weight can I lose on Zepbound?
The specific amount of weight you might lose from Zepbound is uncertain, but significant weight loss ranging from 35.5 lb (16.1 kg) to 52.0 lb (23.6 kg) was observed in the 72-week SURMOUNT-1 clinical trial, which compared different Zepbound (tirzepatide) doses to a placebo (inactive treatment). Zepbound is administered once a week through subcutaneous injection, with doses of 5mg, 10mg, and 15mg tested in the trial.
Participants in the trial had to meet specific criteria: a body-mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related complication (e.g., high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease). They had to be adults over 18 who had previously attempted diet-based weight loss unsuccessfully. No other weight-loss medications were allowed for 90 days before the trial. Individuals with diabetes or a history of planned or previous obesity surgery were ineligible for the SURMONT-1 trial.
The 72-week results for Zepbound (efficacy estimand) for this trial were as follows:
- 5mg/week Zepbound: 16% weight loss or an average reduction of 35.5 lb (16.1 kg)
- 10mg/week Zepbound: 21.4% weight loss or an average reduction of 48.9 lb (22 kg)
- 15mg/week Zepbound: 22.5% weight loss or an average reduction of 52 lb (23.6 kg)
- Placebo: 2.4% weight loss or an average reduction of 5.3 lb (2.4 kg).
After 72 weeks, 85% to 91% of those on Zepbound achieved a body weight reduction of 5% or more, compared to only 35% on placebo. Common side effects included mild to moderate gastrointestinal symptoms like nausea, diarrhea, constipation, indigestion, vomiting, and COVID-19 infection.
Notably, 4.3% of those on 5mg/week Zepbound discontinued treatment due to side effects, compared to 7.1% on 10mg/week and 6.2% on 15mg/week. It's important to remember that clinical trial data may not represent the general population, and individual factors can vary significantly. Always seek personalized medical advice for your specific healthcare decisions.
Related questions
References
- Jastreboff, AM, Aronne, LJ, Ahmad, NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022; 387:205-216 DOI: 10.1056/NEJMoa2206038
- Zepbound Product Label. https://pi.lilly.com/us/zepbound-uspi.pdf?s=pi
Read next
Why am I not losing weight on Mounjaro?
It takes time, about 8 to 12 weeks to see a 6% to 8% weight loss in adults using Mounjaro. Other reasons include the need to follow a reduced calorie diet and exercise program, your dose may need to be increased, or side effects may affect your treatment. Continue reading
Can you get tirzepatide from a compounding pharmacy?
Some pharmacies or clinics may supply compounded versions of medicines like tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) to patients, but the FDA has issued safety warnings about this practice. Concerns have risen over active ingredients, side effects and labeling of these compounded products. Continue reading
Mounjaro for weight loss, does it work? How much will I lose?
Mounjaro's active ingredient has been shown to help with weight loss when used to treat obese patients. Mounjaro's active ingredient tirzepatide is approved for weight loss but under the brand name Zepbound, in studies participants treated with Mounjaro's active ingredient tirzepatide lost between 16.1 kg (35.5 lb) and 23.6 kg (52.0 lb) on average over 72 weeks. Continue reading
Related medical questions
- How do you inject / administer Zepbound?
- How long does it take for Zepbound to work?
- How do Zepbound and Wegovy compare?
- Is Zepbound covered by insurance?
- What happens when you stop taking Zepbound?
Drug information
Related support groups
- Tirzepatide (8 questions, 9 members)
- Zepbound (10 questions, 8 members)
- Weight Loss (Obesity/Overweight) (759 questions, 1,488 members)